Carlsmed (CARL) Earnings Analysis
Carlsmed (CARL) next reports earnings on 2026-08-27, consensus EPS -0.32 USD. Last quarter (2025-11-06) it beat with EPS -0.4 USD vs -0.45 USD est (+11.1%). It has beaten estimates in 2/2 recent quarters (100%). Trailing P/E -4.52.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does CARL next report earnings?
| Next earnings date | 2026-08-27 |
|---|---|
| Consensus EPS estimate | -0.32 USD |
| Revenue estimate | 0.02B |
CARL earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2025-11-06 | -0.4 USD | -0.45 USD | +11.1% | Beat |
| 2025-08-28 | -1.47 USD | -1.52 USD | +3.3% | Beat |
Beat rate: 2/2 (100%) over reported quarters with consensus data.
CARL valuation and analyst view
| Trailing P/E | -4.52 |
|---|---|
| Trailing EPS | -1.23659 USD |
| Price / book | 3.21 |
| Dividend yield | 0.00% |
| Market cap | 0.30B |
| Analyst consensus | Buy (3 buy / 0 hold / 0 sell) |
| Avg price target | 17 USD |
Related research pages
Frequently asked questions
When is Carlsmed (CARL)'s next earnings date?
Carlsmed is next scheduled to report on 2026-08-27, with a consensus EPS estimate of -0.32 USD and revenue estimate of 0.02B.
Did CARL beat earnings last quarter?
In its 2025-11-06 report, CARL posted EPS of -0.4 USD versus a -0.45 USD estimate — a beat of 11.1%.
What is CARL's earnings track record?
Over the last 2 reported quarters with consensus data, CARL beat estimates 2 times (100%).
What is CARL's current P/E ratio and EPS?
CARL trades at a trailing P/E of -4.52 on trailing EPS of -1.2365925107396485 USD.
What do analysts rate CARL?
Analyst consensus is "Buy" across 3 ratings (0 strong buy, 3 buy, 0 hold, 0 sell, 0 strong sell). Average 12-month price target: 17 USD.